METROPOLITAN LIFE INSURANCE CO/NY - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 78 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2023$14,478
-53.8%
9,8490.0%0.00%
-50.0%
Q2 2023$31,320
+34.7%
9,8490.0%0.00%
+100.0%
Q1 2023$23,244
-37.6%
9,849
-8.3%
0.00%
-50.0%
Q4 2022$37,254
-52.7%
10,7360.0%0.00%
-50.0%
Q3 2022$78,695
+12.4%
10,7360.0%0.00%
+33.3%
Q2 2022$69,999
+40.0%
10,736
+8.4%
0.00%
+50.0%
Q1 2022$50,005
-56.7%
9,902
+26.8%
0.00%0.0%
Q3 2021$115,5737,8090.00%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$156,056,00045.49%
Foresite Capital Management IV, LLC 13,282,181$102,804,00021.15%
Apoletto Ltd 15,093,969$116,827,00014.55%
SB Management Ltd 3,500,000$27,090,0002.68%
HSG Holding Ltd 3,045,997$23,576,0002.11%
MIC Capital Management UK LLP 1,320,000$10,217,0001.95%
Alphabet Inc. 5,865,125$45,396,0001.10%
Board of Trustees of The Leland Stanford Junior University 1,647,882$12,754,0000.80%
Adero Partners, LLC 491,372$3,803,0000.62%
Ergoteles LLC 1,008,428$7,805,0000.30%
View complete list of LYELL IMMUNOPHARMA INC shareholders